Background: Henoch-Sch€ onlein purpura (HSP) is a common form of vasculitis in children. It typically involves small vessels of the skin, the gastrointestinal (GI) tract, joints, and kidneys. GI involvement is the most severe short-term complication and GI bleeding is a major complication of HSP, but there is no established predictive marker of GI bleeding. Blood neutrophil-to-lymphocyte ratio (NLR) has been proposed as a potentially useful marker of clinical outcome in diseases with an inflammatory component. The aim of this study was to clarify the association of NLR with HSP and investigate the usefulness of NLR as a marker to predict GI bleeding in children with HSP.
bleeding, but there are no established predictive markers of GI bleeding.
Blood neutrophil-to-lymphocyte ratio (NLR) is a simple marker for systemic inflammation and can be easily determined from the differential white blood cell (WBC) count. [11] [12] [13] [14] Some studies on HSP have reported the association of NLR with GI bleeding. 10, 15 The aim of this study was therefore to assess whether NLR is a reliable marker of GI bleeding and to determine the optimal diagnostic cut-off of NLR for predicting GI bleeding in children with HSP.
Methods

Study design and patient selection
Between June 2005 and December 2017, we retrospectively reviewed the cases of 308 children diagnosed with HSP at Chonnam National University Hospital. According to the European League against Rheumatism/Paediatric Rheumatology European Society criteria for HSP, HSP was defined as palpable purpura (in the absence of coagulopathy or thrombocytopenia) and one or more of the following: (i) abdominal pain (acute, diffuse, or colicky pain); (ii) arthritis or arthralgia; (iii) predominant immunoglobulin (Ig)A deposition indicated in biopsy of affected tissues; and (iv) renal involvement (hematuria or proteinuria). 16 The criteria for exclusion were as follows: (i) underlying disease; (ii) medication prior to blood sampling; or (iii) absence of laboratory data. Of the 308 screened patients, 141 satisfied the inclusion criteria and were enrolled. The patients were divided into two subgroups according to the presence of GI bleeding. Medical records were reviewed for demographic data, clinical symptoms, and laboratory and radiological findings. This study was approved by the institutional review board and followed the guidelines of the Declaration of Helsinki.
Investigation and definitions
The following laboratory data were recorded at the time of diagnosis: WBC, neutrophils, and lymphocytes; platelet counts and MPV; hemoglobin; C-reactive protein (CRP) and albumin; and urinalysis and stool occult blood test results. NLR and PLR were calculated using complete blood count tests. Radiological tests, including intestinal ultrasonography and abdominal computed tomography were performed.
Gastrointestinal involvement was defined as the development of abdominal pain, vomiting or GI bleeding. GI bleeding was defined as the presence of clinical signs of hematochezia, melena, or hematemesis and/or occult blood in stool. Renal involvement was defined as the presence of hematuria (>5 red blood cells per high-power microscopic field) and/or proteinuria (protein concentration in spot urine ≥30 mg/dL or spot urine protein/creatinine ratio >0.5 in children <2 years of age and >0.2 in children ≥2 years of age). A urine protein/creatinine ratio >2 was defined as nephrotic-range proteinuria.
Statistical analysis
Quantitative variables are expressed as mean AE SD, and categorical variables as absolute and relative frequency. Continuous data were analyzed using Student's t-test or MannWhitney U-test, as appropriate, and categorical data were analyzed using chi-squared test. Logistic regression analysis was used to identify the variables associated with GI bleeding in HSP patients. Receiver operating characteristic (ROC) analysis was performed to identify the optimal cut-off of NLR for predicting GI bleeding in HSP patients. P < 0.05 was considered significant. All statistical analysis was performed using SPSS ver. 23.0 (SPSS, Chicago, IL).
Results
A total of 141 HSP patients were enrolled in this study. Mean patient age was 6.6 AE 2.8 years, and 55.3% of the patients were male. Ninety-one patients (64.5%) had arthritis or arthralgia. Sixty-five patients (46.1%) had GI involvement; 15 (10.6%) of these patients had GI bleeding. Forty-three patients (30.5%) had renal involvement and, of these, 32 patients (22.7%) had proteinuria and 13 patients (9.2%) had nephroticrange proteinuria. Laboratory parameters are listed in Table 1 .
The lag time between onset of symptoms and laboratory test ranged from 0 to 19 days with a mean of 3.7 days. In addition, the lag time between laboratory test and detection of GI bleeding ranged from 1 to 19 days with a mean of 4.5 days. NLR (P < 0.001) and neutrophil count (P = 0.011) were significantly higher and lymphocyte count (P = 0.005) was significantly lower in patients with GI involvement than in those without GI involvement (Table 1) . Differences in platelet count were not significant, but PLR was significantly lower in patients with GI involvement (P = 0.037) than in those without GI involvement. Lymphocyte count (P = 0.002) and PLR (P = 0.032) were significantly lower, while NLR (P = 0.001) was significantly higher in patients with GI bleeding than in those without GI bleeding (Table 2 ). There were no statistically significant differences in WBC and neutrophils; platelet count and MPV; hemoglobin; albumin, and CRP according to GI bleeding status.
On logistic regression analysis of PLR and NLR to identify the predictive factors for GI bleeding in HSP (Table 3) , only NLR was associated with GI bleeding in HSP patients (OR, 1.654; P = 0.004). ROC analysis was used to define the diagnostic thresholds of NLR for predicting GI bleeding in HSP patients. The area under the curve of NLR was 0.753 (95% CI: 0.626-0.880; P = 0.001; Fig. 1 ). The optimal cut-off of NLR for predicting GI bleeding was 2.86, with 73% sensitivity and 68% specificity.
Discussion
This study investigated the factors for predicting risk of GI bleeding, which signifies the development of severe GI complications in children with HSP. Of the variables analyzed, including WBC, neutrophil, and lymphocyte counts; platelet and MPV; PLR and NLR; and hemoglobin, albumin, and CRP, NLR was found to be significantly associated with both GI involvement and GI bleeding in children with HSP.
Henoch-Sch€ onlein purpura is the most common form of systemic vasculitis in childhood, mainly affecting small vessels of the skin, joints, the GI tract, and, rarely, kidneys. 1 The clinical outcome of HSP in most children is excellent, with spontaneous resolution of symptoms and signs. Development of major long-term complications depends on the severity of renal involvement, but severe GI involvement can result in significant morbidity and mortality in the acute stage of HSP. 1, 3, 4, 17 Moreover, severe GI involvement requires aggressive treatment, including blood transfusion or surgery, and is also a risk factor for renal involvement. In this study, we investigated useful predictors of GI involvement in the early phase of HSP in patients. Edema and bleeding due to vasculitis on the intestinal wall may lead to invagination, gangrene or perforation. 18 We therefore focused on the prediction of GI bleeding. Increased thrombocytosis, leukocytosis, MPV, and PLR have been reported as risk factors for GI bleeding in HSP patients. [8] [9] [10] NLR has also been reported to be a useful predictive biomarker of GI bleeding in HSP patients. 19, 20 Therefore, we also investigated the usefulness of NLR, a simple and easily obtainable systemic inflammatory biomarker, as a potential predictive marker of GI bleeding in children with HSP. Blood NLR, which can be calculated easily using neutrophil and lymphocyte counts, has been introduced as a potential marker for inflammation in various diseases. [11] [12] [13] [14] The negative impact of elevated NLR on clinical outcome has been noted in cardiovascular disease, 21, 22 cancer, 23 liver cirrhosis, 24 and end-stage renal disease. 25 NLR may reflect the balance between innate (neutrophils) and adaptive (lymphocytes) immune responses, and elevated NLR is associated with an increased concentration of various pro-inflammatory cytokines. 13, 23 In HSP, pro-inflammatory cytokines such as interleukins and tumor necrosis factor are secreted in the acute phase because of inflammation. 26 An association has been reported between NLR and systemic involvement of HSP. 10, 15, 19, 20 These studies confirmed the negative impact of elevated NLR, but they differed in the reported NLR cut-offs. WBC and neutrophil count vary considerably with ethnicity. 27 Studies in patients from Western countries often used higher NLR cut-offs than studies in patients of diverse ethnicities (e.g. Asian and African patients). 11, 12, 27, 28 To our knowledge, no study has examined the NLR for predicting GI bleeding in Asian children. We investigated the usefulness of NLR as a potential marker for GI bleeding and suggested an optimal cut-off of NLR for predicting GI bleeding in children with HSP. In the present study, elevated NLR was significantly correlated with an increased risk of developing GI bleeding in 
05 is considered significant. CRP, C-reactive protein; GI, gastrointestinal; HSP, Henoch-Sch€ onlein purpura; MPV, mean platelet volume; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; WBC, white blood cells. P < 0.05 is considered significant. GI, gastrointestinal; HSP, Henoch-Sch€ onlein purpura; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio. Fig. 1 Receiver operating characteristic analysis of neutrophilto-lymphocyte ratio for the prediction of gastrointestinal bleeding in children with Henoch-Sch€ onlein purpura. Cut-off, 2.86; sensitivity, 73%; specificity, 68%.
HSP patients. The optimal cut-off of NLR for predicting GI bleeding was 2.86 (sensitivity, 73%; specificity, 68%). This is similar to that reported by Makay et al. (cut-off, 2.82; sensitivity, 81%; specificity, 76%). 15 In the present study, on examining the possible risk factors for GI bleeding, PLR was also found to be associated with GI bleeding in HSP patients (P = 0.032; Table 1 ). On logistic regression analysis, however, PLR was not a significant factor. Differences in other factors previously reported to be associated with GI bleeding in HSP patients, such as thrombocytosis, leukocytosis, MPV, and CRP, 8, 9 were not found to be significant in the present study. Given that severe abdominal involvement is a predictor of HSP nephritis, we identified the risk factors for renal involvement. There was no statistically significant difference in any variable with regard to renal involvement status. A high NLR and low PLR showed borderline significance in patients with renal involvement (hematuria and/or proteinuria; data not shown; P = 0.064; P = 0.071, respectively). Further large population-based studies are needed to clarify the significance of NLR in HSP nephritis.
Limitations
The present study had the following limitations. First, this was a retrospective study; therefore, some data were missing from the patient medical records. Second, this study involved a single-center analysis with a restricted number of patients. Therefore, the sample size was small, leading to limitations in statistical power. Third, several types of inflammatory conditions and medications may affect NLR. Therefore, pre-medication results were used, and history of infection was considered, but thyroid function abnormalities and connective tissue diseases, including systemic lupus erythematosus, were not evaluated. Fourth, the elapsed time between blood sample collection and NLR measurement was not determined. Fifth, related cytokines were not tested. Thus, the association between cytokine profile and the prognostic significance of high NLR remains unclear in HSP patients with GI bleeding. Further studies are needed to clarify this.
In this study, NLR was significantly higher in HSP patients with GI bleeding. Therefore, we suggest that blood NLR can be a potential biomarker for predicting GI bleeding in children with HSP.
